Status:

COMPLETED

Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context

Lead Sponsor:

Centre Hospitalier Arras

Conditions:

COVID-19

Obesity

Eligibility:

All Genders

18+ years

Brief Summary

Compare the resting energy expenditure of COVID-19 patients (obese or non-obese) in intensive care unit with mechanical ventilation to a control group of non-COVID-19 intensive care patients.

Eligibility Criteria

Inclusion

  • For the Ambulatory Obese Control Group, the inclusion criteria are:
  • Age ≥ 18 years;
  • Patient followed in the nutrition service;
  • Patient who benefited from an indirect calorimetry whatever the indication between 01/01/20 and 31/12/2020;
  • BMI\> 30.
  • For the COVID Group and the Resuscitation Control Group, the inclusion criteria are:
  • Age ≥ 18 years;
  • Patient having undergone a resuscitation stay
  • Patient on mechanical ventilation (intubated or tracheotomized) during their stay in intensive care;
  • Patient having benefited from an indirect calorimetry upon arrival in intensive care;
  • Only for the COVID Group:
  • Patient hospitalized in intensive care for COVID 19 infection diagnosed by a positive PCR via nasopharyngeal sampling or endotracheal aspiration.
  • Patient who has not yet carried out his post-resuscitation visit;
  • Only for the Resuscitation Control Group:
  • \- Patient hospitalized in intensive care for an indication other than an infectious cause.

Exclusion

  • Non-inclusion criteria for the Ambulatory Obese Control Group:
  • Person deprived of liberty;
  • Person subject to legal protection measures;
  • Patient's opposition to participate in research.
  • The non-inclusion criteria for the COVID Group and the Resuscitation Control Group:
  • For patients intubated during the resuscitation stay Fi02\> 70% which does not allow a correct interpretation of the calorimetry;
  • Pregnancy ;
  • Person deprived of liberty;
  • Person subject to legal protection measures;
  • Opposition of the patient or the person of trust to participate in the research.
  • Only for the COVID Group:
  • Contraindication to indirect calorimetry (claustrophobia for post-resuscitation patients where calorimetry is performed with a mask);
  • Contraindication to bioimpedancemetry (electronic implants, limb amputation, weight \<30kg or\> 300kg);

Key Trial Info

Start Date :

July 3 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 4 2021

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04391686

Start Date

July 3 2020

End Date

November 4 2021

Last Update

March 15 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Arras general hospital

Arras, France, 62000